IceCure Medical (ICCM)
(Real Time Quote from BATS)
$0.70 USD
-0.02 (-2.43%)
Updated Aug 26, 2024 01:36 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for IceCure Medical Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 11 | 24 | 26 | 4 | 6 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 3 | 2 | 1 | 1 |
Other Current Assets | 1 | 1 | 2 | 5 | 0 |
Total Current Assets | 14 | 28 | 30 | 10 | 7 |
Net Property & Equipment | 2 | 1 | 1 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 16 | 30 | 32 | 10 | 7 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 1 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 3 | 3 | 3 | 3 |
Total Current Liabilities | 4 | 4 | 4 | 4 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 1 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 4 | 5 | 5 | 5 | 4 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 3 |
Capital Surplus | 102 | 101 | 85 | 54 | 45 |
Retained Earnings | -90 | -75 | -58 | -49 | -45 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 12 | 25 | 27 | 6 | 3 |
Total Liabilities & Shareholder's Equity | 16 | 30 | 32 | 10 | 7 |
Total Common Equity | 12 | 25 | 27 | 6 | 3 |
Shares Outstanding | 45.60 | 45.60 | NA | NA | NA |
Book Value Per Share | 0.27 | 0.56 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for IceCure Medical Ltd falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10 | 11 | 11 | 4 | 17 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | NA | NA |
Inventories | 2 | 2 | 2 | 3 | 3 |
Other Current Assets | 1 | 1 | 1 | 10 | 1 |
Total Current Assets | 13 | 14 | 14 | 17 | 20 |
Net Property & Equipment | 1 | 1 | 2 | 2 | 2 |
Investments & Advances | NA | 0 | 0 | NA | NA |
Other Non-Current Assets | NA | 0 | 0 | NA | NA |
Deferred Charges | NA | 0 | 0 | NA | NA |
Intangibles | NA | 0 | 0 | NA | NA |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 15 | 16 | 16 | 19 | 23 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | NA | NA |
Accounts Payable | 1 | 1 | 1 | 1 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | NA | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | NA | NA |
Income Taxes Payable | NA | 0 | 0 | NA | NA |
Other Current Liabilities | 4 | 3 | 3 | 3 | 3 |
Total Current Liabilities | 4 | 4 | 4 | 4 | 4 |
Mortgages | NA | 0 | 0 | NA | NA |
Deferred Taxes/Income | NA | 0 | 0 | NA | NA |
Convertible Debt | NA | 0 | 0 | NA | NA |
Long-Term Debt | NA | 0 | 0 | NA | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | NA | NA | |
Minority Interest (Liabilities) | NA | 0 | 0 | NA | NA |
Total Liabilities | 5 | 4 | 4 | 5 | 4 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | NA | NA |
Common Stock (Par) | NA | 0 | 0 | NA | NA |
Capital Surplus | 107 | 105 | 102 | 102 | 102 |
Retained Earnings | -97 | -94 | -90 | -87 | -83 |
Other Equity | NA | 0 | 0 | NA | NA |
Treasury Stock | NA | 0 | 0 | NA | NA |
Total Shareholder's Equity | 11 | 12 | 12 | 15 | 18 |
Total Liabilities & Shareholder's Equity | 15 | 16 | 16 | 19 | 23 |
Total Common Equity | 100,010 | 12 | 12 | 100,014 | 100,017 |
Shares Outstanding | 45.60 | 45.60 | 45.60 | 45.60 | 45.60 |
Book Value Per Share | 2,193.19 | 0.26 | 0.27 | 2,193.28 | 2,193.36 |